Related Experiment Video
Updated: May 4, 2026

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes
Ying-zhong Lin1, Shan-he Lu1, Zheng-de Lu1
1Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Insights
Regulatory T (Treg) cells, including CD4+LAP+ Tregs, are decreased in acute coronary syndromes (ACS). This reduction in regulatory T cells and associated cytokines may contribute to ACS onset.
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Regulatory T (Treg) cells are crucial in atherosclerosis and acute coronary syndromes (ACS).
- CD4+LAP+ Treg cells, a novel subset, show promise in ameliorating atherosclerosis and are present in humans.
- The study investigates the role of CD4+LAP+ Treg cells in the onset of ACS.
Purpose of the Study:
- To determine the involvement of CD4+LAP+ Treg cells in the onset of acute coronary syndromes (ACS).
- To compare frequencies of CD4+LAP+ and CD4+CD25+ Treg cells in ACS patients versus controls.
Main Methods:
- Flow cytometry was used to quantify CD4+LAP+ and CD4+CD25+ Treg cell frequencies.
- ELISA measured plasma levels of IL-10 and TGF-β1.
- Study included patients with stable angina (SA), non-ST-elevation ACS (NSTEACS), ST-elevation myocardial infarction (STEMI), and healthy controls.
Main Results:
- Patients with ACS exhibited significantly lower frequencies of CD4+LAP+ and CD4+CD25+ Treg cells compared to SA and control groups.
- Reduced levels of IL-10 and TGF-β1 were observed in ACS patients.
- A significant decrease in regulatory T cell populations and key cytokines was noted in ACS.
Conclusions:
- A diminished frequency of CD4+LAP+ and CD4+CD25+ Treg cells may be implicated in the pathogenesis of ACS.
- The findings suggest a potential role for these Treg subsets in ACS development.
Background:
Regulatory T (Treg) cells play a protective role in atherosclerosis prone models and are related to the onset of acute coronary syndromes (ACS, including non-ST-elevation ACS (NSTEACS) and ST-elevation acute myocardial infarction (STEAMI)). CD4+LAP+ Treg cells are a novel subset of Tregs that have been found to ameliorate atherosclerosis in ApoE(-/-) mice, and these cells also exist in humans. The present study was designed to investigate whether CD4+LAP+ Treg cells are involved in the onset of ACS.
Methods:
The frequencies of CD4+LAP+ and CD4+CD25+ Treg cells were detected using flow cytometric analysis, and the plasma IL-10 and TGF- β 1 levels were measured using an ELISA in 29 stable angina (SA) patients, 30 NSTEACS patients, 27 STEAMI patients, and a control group (30 cases).
Results:
The results revealed a significant decrease in the frequencies of CD4+LAP+ and CD4+CD25+ Treg cells and in the levels of IL-10 and TGF- β 1 in patients with ACS compared with those in the SA and control groups.
Conclusions:
The decrease in the frequencies of CD4+LAP+ and CD4+CD25+ Treg cells may play a role in the onset of ACS.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Coronary Artery Disease II: Pathophysiology

